1. Cochrane Review Ignites New Fire in Alzheimer's Amyloid Drug Debate
A major scientific review has reignited a fierce and long-running battle over the fundamental premise of Alzheimer's disease treatment. A sweeping Cochrane review is fueling fresh, intense debate over the effectiveness of amyloid-targeting drugs, the dominant class of therapies for the condition. This development strik...